Evidence Summary
- Evidence Level
- Preliminary
- Mechanism
- Enrollment: Estimated, Sponsor Type: Other, Unknown / General
- Safety
- Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
- Dosing
- See linked studies/trials for reported doses and durations; typical protocols vary widely.
Plasma levels inversely correlated with PASC severity. 1-3g/day raises levels. Mitochondrial + NF-kB rationale. Safe; may help energy/autonomic symptoms. Good mechanistic support, limited direct trials.
Clinical Trials
2 trial(s) registered
| NCT ID | Title | Phase | Status |
|---|---|---|---|
| NCT06721949 | Taurine Supplementation in Long COVID | Phase 2 | Recruiting |
| NCT07682402 | Taurine Supplementation in Adolescents With Post-COVID Condition | Phase 1 | Not yet recruiting |
Key Studies / References
- See linked studies